Abstract
Greystone Research Associates is pleased to announce the publication of a new
market study. Insulin Patch Pumps: Devices, Markets, Players and Prospects is
a comprehensive evaluation and analysis of the technology, products and
participants providing the driving force behind this evolving segment of the
drug delivery sector.
The study is designed to provide drug company decision makers, drug delivery
developers, device designers, healthcare marketers, and supply chain
participants with a detailed understanding of the economics, technologies,
treatment segments, and commercial opportunities for integrated devices that
couple a transdermal drug device format with an active delivery technology.
Provider organization business managers, healthcare administrators and
investors will also benefit from this study.
User Friendly Devices and Improved Patient Compliance
The collapse of the inhaled insulin market in 2008 has resulted in programs
focused on alternative insulin delivery technologies. It now appears that the
patch pump - a device that represents the convergence of a transdermal
reservoir system with an energy source and control technology - will be the
next generation in the evolution in patient-friendly insulin administration.
With four FDA-approved insulin patch pump products and twice as many serious
development-stage devices, the next 36 months will be critical to market
sector participants wishing to ascend to a leadership position in the market
segment. With no room for post-market missteps, product reliability,
ease-of-use and patient acceptance will be essential for market success.
Feature Summary
- Analyzes and evaluates patch pump products and assesses the market
potential for existing and pipeline products
- Analyzes product design strategies, technologies and market development
issues
- Provides detailed descriptions of insulin patch pump market segments,
market demographics, and business strategies
- Provides market data and forecasts to 2015
- Profiles patch pump product companies, their product development
activities, business strategies, and corporate alliances and affiliations
- Assesses the importance of IP and design partnerships on active insulin
patch products
- Evaluates the impact of economic, technology, and regulatory factors on
insulin delivery markets
Report Format and Availability
This report is available in electronic format.
Methodology
Research methodology is based on primary research in the form of in-depth
interviews with key market participants, technology developers, distributors,
industry experts, and market influencers, a list that includes regulatory
officials, industry trade groups, and materials standards organizations.
Primary data is evaluated and normalized against secondary sources including
trade journal articles, technical literature, industry publications, company
data sheets and published information, and statistical data from government
agencies and trade associations.
Forecasts and projections of market demand and future market activity are
derived using standard modeling and statistical techniques.
About Greystone Research Associates
Greystone Research Associates is a medical technology consulting firm focused
on the areas of medical market strategy, product commercialization, venture
development, and market research. We assist medical and healthcare market
participants in achieving their business objectives through the creation of
detailed development strategies, product commercialization programs, and
comprehensive market and technology research and analysis.
Our market research publications are designed, researched and written to
provide timely and insightful information and data on focused market segments,
with the aim of providing market participants with the essential knowledge to
refine and execute their marketing plans and financial targets.
Table of Contents
Executive Summary
Diabetes Management Market Dynamics
- Shifting Insulin Delivery Markets
- Demand Drivers
- Demographic Shifts
- Managed Care Initiatives
- Growth in Home Healthcare
- Patient Compliance
- Technology Market Drivers
- Competitive Landscape
Patch Pump Device Strategies
- Device/System Architecture
- Drug Delivery Mechanism
- Drug Reservoirs
- Sized Patch Pumps
- Handheld Remote Electronics
- Accuracy and Dosing Variability
- Alerts and Patient Notification
- Special Features
FDA-Approved Insulin Patch Pumps - Analysis and Market Data
- Finesse
- OmniPod
- Solo
- V-Go
Development-Stage Insulin Patch Pumps - Assessments & Forecasts
- Cellnovo
- CeQur
- Freehand
- Jewel Pump
- Medipacs
- PassPort
- Sensile Medical
- Spring Hybrid Pump
- SteadyMed
Market Factors
- Regulations
- Trials & Approval
- IP and Product Positioning
Sector Participant Company Profiles
Insulin Patch Pumps published by Greystone Research Associates in November 9, 2011. This report price starts from US $ 2850.
